Work

Adults 55 Years and Older with Multiple Sclerosis (MS) Treated with Ocrelizumab: Characteristics and Outcomes Over More Than 13,000 Person-Months (P10-1.013)

Year: 2025

Type: article

Study design: Observational Study

Source: Neurology

DOI: 10.1212/wnl.0000000000210949

Authors: Seungwon Lee, Raphael Scheu, Maya Mastick, Farrah Mateen

Institutions: Massachusetts General Hospital, University of Cambridge, Harvard University

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409228425

FWCI: 0.598

Cites:

Cited by: 1

Related to: 10